Back
Edgewise Therapeutics Stock Predictions
Buy
53
EWTX
Edgewise Therapeutics
Last Price:
16.72
Seasonality Move:
-4.2%
7 Day Trial
ALL ACCESS PASS
$
7
Edgewise Therapeutics Stock Forecast
- Over the next 52 weeks, Edgewise Therapeutics has on average historically risen by 19.9% based on the past 3 years of stock performance.
- Edgewise Therapeutics has risen higher in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
-
Is Edgewise Therapeutics Stock Undervalued?
The current Edgewise Therapeutics [EWTX] share price is $17.05. The Score for EWTX is 53, which is 6% above its historic median score of 50, and infers lower risk than normal. - EWTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Edgewise Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Edgewise Therapeutics has on average historically risen by 19.9% based on the past 3 years of stock performance.
Edgewise Therapeutics Stock Rating
Buy
53
Edgewise Therapeutics (EWTX)
is a Buy
Is Edgewise Therapeutics overpriced?
- Edgewise Therapeutics has risen higher in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
Edgewise Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
edgewisetx.com
52-Week Data
52-Week High:
21.60
52-Week Low:
5.12
Prediction Charts
Market Cap:
1.59B
Price in USD:
17.05
Volume:
757.24K
Beta:
0.13
Technical Analysis
SMA50:
17.50
SMA100:
17.49
SMA200:
12.68
52-Wk Change:
113.93%
Stock Predictions
-
Is Edgewise Therapeutics stock public?
Yes, Edgewise Therapeutics is a publicly traded company. -
What is the Edgewise Therapeutics stock quote today?
The Edgewise Therapeutics stock price is 17.05 USD today. -
How to buy Edgewise Therapeutics stock online?
You can buy Edgewise Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Jun-3 | 17.41 | 17.39 | 17.99 | 17.00 |
Jun-4 | 17.43 | 17.44 | 17.56 | 16.89 |
Jun-5 | 17.58 | 18.01 | 18.16 | 17.36 |
Jun-6 | 17.96 | 17.61 | 18.44 | 17.55 |
Jun-7 | 17.36 | 17.66 | 17.96 | 17.15 |
Jun-10 | 17.45 | 17.13 | 17.74 | 16.96 |
Jun-11 | 16.80 | 17.10 | 17.18 | 16.50 |
Jun-12 | 17.70 | 17.87 | 18.17 | 17.20 |
Jun-13 | 17.80 | 17.89 | 18.13 | 17.55 |
Jun-14 | 17.62 | 17.51 | 18.00 | 17.20 |
Jun-17 | 17.46 | 17.37 | 17.72 | 17.13 |
Jun-18 | 17.27 | 16.18 | 17.27 | 15.87 |
Jun-20 | 16.04 | 16.80 | 17.14 | 16.04 |
Jun-21 | 17.02 | 17.05 | 17.76 | 17.01 |
Edgewise Therapeutics Earnings
Edgewise Therapeutics Earnings Report: Per Share Edgewise Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Edgewise Therapeutics Forecast Revenue Growth
Edgewise Therapeutics Stock Analysis: Historical quarterly revenues per share for Edgewise Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.06 per share, a decrease this year of $0.05 per share, and a decrease next year of $0.39 per share.
* Edgewise Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.